For the quarter ending 2025-09-30, GOSS made $13,294K in revenue. -$48,240K in net income. Net profit margin of -362.87%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total revenue | 13,294 | 11,489 | 9,889 | 9,480 |
| Research and development | 45,542 | 41,575 | 38,041 | 34,897 |
| In process research and development | 7,476 | - | - | - |
| General and administrative | 9,390 | 8,679 | 8,658 | 8,502 |
| Total operating expenses | 62,408 | 50,254 | 46,699 | 43,399 |
| Loss from operations | -49,114 | -38,765 | -36,810 | -33,919 |
| Interest income | 687 | 542 | 294 | 430 |
| Interest expense | 2,748 | 2,744 | 2,746 | 2,734 |
| Other income, net | 2,954 | 2,694 | 2,624 | 4,288 |
| Total other income, net | 893 | 492 | 172 | 1,984 |
| Loss before provision (benefit) for income taxes | -48,221 | -38,273 | - | -31,935 |
| Provision (benefit) for income taxes | 0 | 0 | - | -1,132 |
| Net loss | -48,221 | -38,273 | -36,638 | -30,803 |
| Foreign currency translation | -130 | -4,195 | -1,903 | -2,260 |
| Unrealized gain (loss) on marketable securities | 111 | -69 | -110 | 547 |
| Other comprehensive loss | -19 | -4,264 | -2,013 | -1,713 |
| Comprehensive loss | -48,240 | -42,537 | -38,651 | -32,516 |
| Net loss per share, basic (in dollars per share) | -0.21 | -0.17 | -0.16 | -0.14 |
| Net loss per share, diluted (in dollars per share) | -0.21 | -0.17 | -0.16 | -0.14 |
| Weighted average common shares outstanding, basic (in shares) | 227,981,475 | 227,275,466 | 226,818,051 | 226,346,058 |
| Weighted average common shares outstanding, diluted (in shares) | 227,981,475 | 227,275,466 | 226,818,051 | 226,346,058 |
Gossamer Bio, Inc. (GOSS)
Gossamer Bio, Inc. (GOSS)